Medtronic Garners Bilateral Activa Medicare Reimbursement In 33 States

Medtronic Neurological President Scott Ward acknowledges that current off-label use of the company's Activa deep brain stimulation device for the bilateral treatment of Parkinson's tremor may dampen sales expectations once FDA approves the indication.

More from Archive

More from Medtech Insight